Pfizer
Mrs. Serra completed a post-graduate research project on the global epidemiology of staphylococcus and enterococcus resisting to antibiotics at the Instituto de Tecnologia Química e Biológica António Xavier (ITQB NOVA, Portugal), before receiving her degree in Biotechnology from the Universidade Nova de Lisboa, Portugal. She is currently a Senior Director in the Pfizer Biopharmaceutical Group working directly with Emerging Markets and China where she is a Scientific Affairs Expert and Medical Affairs Lead for their meningococcal vaccines. Mrs. Serra has worked at Pfizer for nearly 18 years and in the past 10 years has dedicated her work to better understand meningococcal disease and meningococcal vaccines.
Moderator of 1 Session
Session Type
Industry Sponsored Symposium
Date
Tue, 22.02.2022
Session Time
11:00 AM - 12:30 PM
Room
Sala A
Session Description
Taking control over Meningococcal Disease: Is now the time? - Symposium Supported by PfizerSession Description:This symposium will:•Appeal for support for the WHO Roadmap on defeating meningitis •Highlight the effects of vaccination in S America •Show how IMD can be prevented and the need for more comprehensive vaccines
Presenter of 4 Presentations
Welcome and introduction
Session Name
Session Type
Industry Sponsored Symposium
Date
Tue, 22.02.2022
Session Time
11:00 AM - 12:30 PM
Room
Sala A
Presenter
Lecture Time
11:00 AM - 11:05 AM
Defeating meningitis in the COVID-19 era
Session Name
Session Type
Industry Sponsored Symposium
Date
Tue, 22.02.2022
Session Time
11:00 AM - 12:30 PM
Room
Sala A
Presenter
Lecture Time
11:05 AM - 11:20 AM
Conclusion
Session Name
Session Type
Industry Sponsored Symposium
Date
Tue, 22.02.2022
Session Time
11:00 AM - 12:30 PM
Room
Sala A
Presenter
Lecture Time
12:00 PM - 12:05 PM
Live Q&A
Session Name
Session Type
Industry Sponsored Symposium
Date
Tue, 22.02.2022
Session Time
11:00 AM - 12:30 PM
Room
Sala A
Presenter
Lecture Time
12:05 PM - 12:30 PM